Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with
Ting Liu1, Congjie Zhai2, Bo Tian1
1Department of Endoscopy Center, The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang, 050031, Hebei, China.
Abstract:
Roundabout guidance receptor 2 (Robo2) is closely related to malignant tumors such as pancreatic cancer and liver fibrosis, but there is no relevant research on the role of Robo2 in HCC. The study will further explore the function and mechanism of Robo2 and its downstream target genes in HCC. Firstly, Robo2 protein levels in human HCC tissues and paired adjacent normal liver tissues were detected. Then we established HepG2 and Huh7 hepatoma cell lines with knock-down Robo2 by transfection with lentiviral vectors, and examined the occurrence of EMT, proliferation and apoptosis abilities in HCC cells by western blot, flow cytometry, wound healing assay and TUNEL staining. Then we verified the interaction between Robo2 and its target gene by Co-IP and immunofluorescence co-staining, and further explored the mechanism of Robo2 and YB-1 by rescue study. The protein expression level of Robo2 in HCC was considerably higher than that in the normal liver tissues. After successfully constructing hepatoma cells with knock-down Robo2, it was confirmed that down-regulated Robo2 suppressed EMT and proliferation of hepatoma cells, and accelerated the cell apoptosis. High-throughput sequencing and validation experiments verified that YB-1 was the downstream target gene of Robo2, and over-expression of YB-1 could reverse the apoptosis induced by Robo2 down-regulation and its inhibitory effect on EMT and proliferation. Robo2 deficiency inhibits EMT and proliferation of hepatoma cells and augments the cell apoptosis by regulating YB-1, thus inhibits the occurrence of HCC and provides a new strategy for the treatment of HCC.
Insights
Roundabout guidance receptor 2 (Robo2) is upregulated in hepatocellular carcinoma (HCC). Inhibiting Robo2 suppresses tumor growth and EMT by regulating YB-1, offering a new HCC treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Roundabout guidance receptor 2 (Robo2) is linked to various cancers, but its role in hepatocellular carcinoma (HCC) remains unexplored.
- Understanding Robo2's function in HCC is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the role and mechanism of Robo2 in HCC.
- To identify Robo2's downstream targets and their involvement in HCC progression.
Main Methods:
- Robo2 protein levels were measured in HCC and adjacent normal tissues.
- Robo2 knockdown was performed in HepG2 and Huh7 cell lines using lentiviral vectors.
- Epithelial-mesenchymal transition (EMT), proliferation, and apoptosis were assessed using western blot, flow cytometry, wound healing, and TUNEL assays.
- Interactions were verified via Co-IP and immunofluorescence; rescue studies explored the Robo2-YB-1 mechanism.
Main Results:
- Robo2 expression was significantly higher in HCC tissues compared to normal tissues.
- Robo2 knockdown suppressed EMT and proliferation while enhancing apoptosis in HCC cells.
- YB-1 was identified as a downstream target of Robo2.
- YB-1 overexpression reversed the effects of Robo2 knockdown on apoptosis, EMT, and proliferation.
Conclusions:
- Robo2 deficiency inhibits HCC progression by suppressing EMT and proliferation and augmenting apoptosis through YB-1 regulation.
- Targeting Robo2 presents a potential new therapeutic avenue for HCC treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
